![Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer | Nature Medicine Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-023-02240-8/MediaObjects/41591_2023_2240_Fig1_HTML.png)
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer | Nature Medicine
![Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3,](https://www.thelancet.com/cms/attachment/66f40219-c969-43b7-b5d9-faf091f79dc7/gr1.gif)
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3,
![IJMS | Free Full-Text | Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion IJMS | Free Full-Text | Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion](https://www.mdpi.com/ijms/ijms-23-15264/article_deploy/html/images/ijms-23-15264-g001.png)
IJMS | Free Full-Text | Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion
![Covid-19 Challenge, al via il bando di Università Campus Bio-Medico e Marzotto Venture Accelerator - la Repubblica Covid-19 Challenge, al via il bando di Università Campus Bio-Medico e Marzotto Venture Accelerator - la Repubblica](https://www.repstatic.it/content/nazionale/img/2020/03/31/175745526-70147319-3a95-4ddc-a04f-963852db6e9e.jpg)